bibliographicCitation |
Battram C, Charlton SJ, Cuenoud B, Dowling MR, Fairhurst RA, Farr D, Fozard JR, Leighton-Davies JR, Lewis CA, McEvoy L, Turner RJ, Trifilieff A. In Vitro and in Vivo Pharmacological Characterization of 5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (Indacaterol), a Novel Inhaled β2Adrenoceptor Agonist with a 24-h Duration of Action. J Pharmacol Exp Ther. 2006 Jan 24;317(2):762–70. doi: 10.1124/jpet.105.098251. |